Skip to content
Governance Register

← US public companies

Ecor1 Capital, LLC

SEC-identified person · CIK 1587114 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Atara Biotherapeutics, Inc. ATRA Officer filed 2026 - 2026
First Tracks Biotherapeutics, Inc. TRAX Officer filed 2026 - 2026
Aktis Oncology, Inc. AKTS Director filed 2026 - 2026
Adaptimmune Therapeutics PLC ADAP] Officer filed 2024 - 2025
Zymeworks Inc. ZYME Director filed 2022 - 2025
Iteos Therapeutics, Inc. ITOS Officer filed 2025 - 2025
Prothena Corp plc PRTA Officer filed 2019 - 2025
Anaptysbio, INC ANAB Director filed 2021 - 2025
Mersana Therapeutics, Inc. [MRSN] Officer filed 2023 - 2024
Tango Therapeutics, Inc. TNGX Officer filed 2023 - 2024
Mirati Therapeutics, Inc. mrtx Officer filed 2023 - 2023
Panacea Acquisition Corp PANA Director filed 2020 - 2023
Tscan Therapeutics, Inc. TCRX Officer filed 2023 - 2023
Panacea Acquisition Corp. II PANA Director filed 2021 - 2023
Voyager Therapeutics, Inc. VYGR Officer filed 2022 - 2023
Lenz Therapeutics, Inc. LENZ Officer filed 2023 - 2023
Odonate Therapeutics, LLC ODT Officer filed 2021 - 2021
Corvus Pharmaceuticals, Inc. CRVS Officer filed 2021 - 2021
Surface Oncology, Inc. SURF Officer filed 2020 - 2020
Akouos, Inc. AKUS Officer filed 2020 - 2020
Eiger Biopharmaceuticals, Inc. EIGR Officer filed 2015 - 2015
Genvec INC GNVC Officer filed 2013 - 2014

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.